Jane Street Group, LLC Reata Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $675,508 - $898,489	-8,527 Reduced 10.79%	70,516 $7.19 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $845,845 - $2.55 Million	27,418 Added 53.11%	79,043 $7.19 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $1.14 Million - $2.17 Million	51,625 New	51,625 $1.96 Million
Q2 2022 Aug 16, 2022	BUY	$20.71 - $36.5 $1.28 Million - $2.25 Million	61,622 Added 418.37%	76,351 $2.32 Million
Q1 2022 May 17, 2022	BUY	$24.12 - $39.6 $17,052 - $27,997	707 Added 5.04%	14,729 $483,000
Q4 2021 Feb 15, 2022	BUY	$25.61 - $110.96 $241,732 - $1.05 Million	9,439 Added 205.96%	14,022 $370,000
Q3 2021 Nov 16, 2021	SELL	$100.0 - $143.02 $47,800 - $68,363	-478 Reduced 9.44%	4,583 $462,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $1.05 Million - $2.03 Million	-13,413 Reduced 72.6%	5,061 $716,000
Q1 2021 May 18, 2021	BUY	$94.25 - $132.81 $508,950 - $717,174	5,400 Added 41.3%	18,474 $1.84 Million
Q4 2020 Feb 17, 2021	SELL	$102.03 - $184.62 $4.69 Million - $8.5 Million	-46,015 Reduced 77.87%	13,074 $1.62 Million
Q3 2020 Nov 17, 2020	BUY	$93.53 - $163.34 $705,496 - $1.23 Million	7,543 Added 14.63%	59,089 $5.76 Million
Q2 2020 Aug 17, 2020	BUY	$126.3 - $176.56 $3.86 Million - $5.4 Million	30,592 Added 146.0%	51,546 $8.04 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $2.06 Million - $4.11 Million	16,587 Added 379.83%	20,954 $3.02 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $325,647 - $951,656	4,367 New	4,367 $893,000
Q2 2019 Aug 15, 2019	SELL	$77.72 - $94.35 $214,351 - $260,217	-2,758 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$51.9 - $101.79 $143,140 - $280,736	2,758 New	2,758 $236,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account